Attenuation of apoptosis and the eye of the beholder

Coronary Artery Disease

Volumn 19, Issue 1, 2008, Pages 55-58

  Sobel, Burton E ^a,b   Zaman, Tarikuz ^a   Budd, Ralph C ^a   Schneider, David J ^a   Taatjes, Douglas J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Cell death; Myocardial infarction; Myocardial salvage; Necrosis; Preservation of myocardium

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

APOPTOSIS; CELL DEATH; CELL SWELLING; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; MITOCHONDRION SWELLING; MYOCARDIAL HIBERNATION; NICK END LABELING; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; REVIEW; STAINING; VALIDATION PROCESS;

ANIMALS; APOPTOSIS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING;

EID: 40449098202     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f19b14     Document Type: Review

References (44)

1. Maroko PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, et al. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972; 45:1160-1172.
2. Shell WE, Sobel BE. Protection of jeopardized ischemic myocardium by reduction of ventricular afterload. N Engl J Med 1974; 291:481-486.
3. Sobel BE, Braunwald E. Management of acute myocardial infarction. In: Braunwald E, editor. Heart disease. Philadelphia: W.B. Saunders; 1980. pp. 1353-1386.
4. Gogo P, Dauerman HL, Sobel BE. Prompt reperfusion: the linchpin of treatment for ST elevation myocardial infarction (STEMI). In: Brown D, Jeremias A, editors. Cardiac intensive care. 2nd ed. Philadelphia: Elsevier (in press).
5. Chance B. Pyridine nucleotide as an indicator of the oxygen requirements for energy-linked functions of mitochondria. Circ Res 1876; 38:I-31-I-38.
6. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size versus duration of coronary occlusion in dogs. Circulation 1977; 56:786-794.
7. Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40:633-644.
8. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995; 76:479-488.
9. Vatner DE, Vatner SF. Physiological and biochemical adrenergic regulation of the stunned myocardium. Mol Cell Biochem 1998; 186:131-137.
10. Rahimtoola SH, La Canna G, Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 2006; 47:978-980.
11. Sobel BE, Shell WE. Jeopardized, blighted, and necrotic myocardium. Circulation 1973; 47:215-216.
12. Zaman AKMT, Fujii S, Schneider DJ, Taatjes DJ, Lijnen HR, Sobel BE. Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. Histochem Cell Biol 2007; 128:135-145.
13. Chan Y, Kelm RJ Jr, Budd RC, Sobel BE, Schneider DJ. Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. J Cell Biochem 2004; 92:178-188.
14. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 2003; 100:4802-4806.
15. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108:79-85.
16. Van Cruchten S, Van den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 2002; 31:214-223.
17. Ferrandi C, Ballerio R, Gaillard P, Giachetti C, Carboni S, Vitte PA, et al. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol 2004; 142:953-960.
18. Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, et al. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 2007; 115:1885-1894.
19. Zhao ZQ, Morris CD, Budde-JM, Wang NP, Muraki S, Sun HY, et al. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res 2003; 59:132-142.
20. Oskarsson HJ, Coppey L, Weiss RM, Li W-G. Antioxidant therapy attenuates myocyte apoptosis in the remote noninfarcted myocardium after large myocardial infarction. Biochem Biophys Res Commun 2001; 280:353-357.
21. Kin H, Wang NP, Halkos ME, Kerendi F, Guyton RA, Zhao ZQ. Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion. Surg Res 2006; 135:170-178.
22. Zhao ZQ, Budde JM, Morris C, Wang NP, Valez DA, Muraki S, et al. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol 2001; 33:57-68.
23. Wang N, Minatoguchi S, Chen X, Uno Y, Arai M, Lu C, et al. Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart. Br J Pharmacol 2004; 142:983-990.
24. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000; 45:651-660.
25. Kobara M, Tatsumi T, Kambayashi D, Mano A, Yamanaka S, Shiraishi J, et al. Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model. J Cardiovasc Pharmacol 2003; 41:880-889.
26. McCully JD, Wakiyama H, Hsieh YJ, Jones M, Levitsky S. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2004; 286:1923-1935.
27. Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmerman R, et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 2000; 32:197-208.
28. Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, et al. Apoptotic myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 1998; 98:1422-1430.
29. Ren J, Zhang S, Kovacs A, Wang Y, Muslin AJ. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J Mol Cell Cardiol 2005; 38:623-627.
30. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, et al. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 2006; 70:457-465.
31. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
32. Takemura G, Fujiwara H. Morophologic aspects of apoptosis in heart diseases. J Cell Mol Med 2006; 10:56-75.
33. Taatjes DJ, Wadsworth MP, Zaman AKMT, Schneider DJ, Sobel BE. A novel dual staining method for identification of apoptotic cells reveals a modest apoptotic response in infracted mouse myocardium. Histochem Cell Biol 2007; 128:275-283.
34. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Physiol 1995; 146:3-13.
35. Li PD, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-489.
36. Moffitt KL, Martin SL, Walker B. The emerging role of serine proteases in apoptosis. Biochem Soc Trans 2007; 35:559-560.
37. Kjekshus JK, Sobel BE. Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res 1970; 27:403-414.
38. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971; 50:2614-2626.
39. Keyes JW, Leonard PF, Brody SL, Svetkoff DJ, Rogers WL, Lucchesi BR. Myocardial infarction quantification in the dog by single photon emission computed tomography. Circulation 1978; 58:227-232.
40. Weiss ES, Ahmed SA, Welch MJ, Williamson JR, Ter-Pogossian MM, Sobel BE. Quantification of infarction in cross sections of canine myocardium in vivo with positron emission transaxial tomography and 11C-palmitate. Circulation 1977; 55:66-73.
41. Lieberman AN, Weiss JL, Jugdutt BI, Becker LC, Bulkley BH, Garrison JG, et al. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981; 63:739-746.
42. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992-2002.
43. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Thompson CB. Growth factor can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001; 21:5899-5912.
44. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007; 204:2089-2102.